000 | a | ||
---|---|---|---|
999 |
_c7754 _d7754 |
||
003 | OSt | ||
005 | 20181204114435.0 | ||
008 | 181204b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_96496 _aPuranik, H.H. |
||
245 | _aSynthesis and anti-diabetic activity of some aryloxypropanolamine derivatives | ||
250 | _aVol.55 (10) | ||
260 |
_aMumbai _bIndian Drug Manufacture's Association - IDMA _c2018 |
||
300 | _a16-23p. | ||
520 | _aAryloxypropanolamine plays an important role in several biological activities. It shows multiple actions such as β-blocking, anxiolytic, antihypertensive and inhibition of cytochrome p450. A series of ten aryloxypropanolamine derivatives 6a–6j were synthesized and evaluated for anti-diabetic activity. Two compounds 6b to 6g have shown good anti-diabetic activity. All synthesized compounds (6a-6j) were evaluated for their anti-diabetic activity in STZ induced diabetes model of Wistar rats. | ||
650 | 0 |
_94639 _aPHARMACEUTICS |
|
653 | _aNMR | ||
653 | _aSTZ induced model | ||
700 |
_96497 _aJadhav, S.B. |
||
700 |
_96498 _aBandawane, D.D. |
||
700 |
_96499 _aBhalekar, P.A. |
||
773 | 0 |
_tIndian drugs _dMumbai Indian Drug Manufactures Association |
|
942 |
_2ddc _cAR |